Non-femoral focused transaxillary access in TAVI: GARY data analysis and future trends
Background In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen. Aim To evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to fur...
Saved in:
Published in | Clinical research in cardiology Vol. 114; no. 3; pp. 323 - 331 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.03.2025
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 1861-0684 1861-0692 1861-0692 |
DOI | 10.1007/s00392-024-02402-9 |
Cover
Abstract | Background
In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.
Aim
To evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access.
Methods
All patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach.
Results
Overall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%,
p
= 0.006; TAo 92.22% vs. TAx 95.59%,
p
= 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%;
p
< .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days;
p
< .001) after TAx access.
Conclusion
It may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches.
Graphical Abstract |
---|---|
AbstractList | BackgroundIn patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.AimTo evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access.MethodsAll patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach.ResultsOverall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p = 0.006; TAo 92.22% vs. TAx 95.59%, p = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p < .001) after TAx access.ConclusionIt may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches. Background In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen. Aim To evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access. Methods All patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach. Results Overall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p = 0.006; TAo 92.22% vs. TAx 95.59%, p = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p < .001) after TAx access. Conclusion It may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches. Graphical Abstract In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen. To evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access. All patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach. Overall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p = 0.006; TAo 92.22% vs. TAx 95.59%, p = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p < .001) after TAx access. It may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches. In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.BACKGROUNDIn patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.To evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access.AIMTo evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access.All patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach.METHODSAll patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach.Overall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p = 0.006; TAo 92.22% vs. TAx 95.59%, p = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p < .001) after TAx access.RESULTSOverall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p = 0.006; TAo 92.22% vs. TAx 95.59%, p = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p < .001) after TAx access.It may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches.CONCLUSIONIt may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches. |
Author | Walther, Thomas Bekeredjian, Raffi Eghbalzadeh, Kaveh Beyersdorf, Friedhelm Rudolph, Tanja K. Frerker, Christian Seiffert, Moritz Meertens, Max M. Beckmann, Andreas Adam, Matti Balaban, Ümniye Sinning, Jan-Malte Bleiziffer, Sabine Ensminger, Stephan Möllmann, Helge |
Author_xml | – sequence: 1 givenname: Max M. orcidid: 0000-0002-7746-8723 surname: Meertens fullname: Meertens, Max M. email: max.meertens@me.com organization: Department III of Internal Medicine, University Hospital of Cologne – sequence: 2 givenname: Matti surname: Adam fullname: Adam, Matti organization: Department III of Internal Medicine, University Hospital of Cologne – sequence: 3 givenname: Andreas surname: Beckmann fullname: Beckmann, Andreas organization: Department of Cardiac and Pediatric Cardiac Surgery, Evanglish Clinical Center Niederrhein, Heart Center Duisburg – sequence: 4 givenname: Stephan surname: Ensminger fullname: Ensminger, Stephan organization: Department of Cardiac and Thoracic Vascular Surgery, University Heart Center Lübeck, University Hospital of Schleswig Holstein, German Center for Cardiovascular Research (DZHK), Partner Sie Hamburg-Kiel-Lübeck – sequence: 5 givenname: Christian surname: Frerker fullname: Frerker, Christian organization: German Center for Cardiovascular Research (DZHK), Partner Sie Hamburg-Kiel-Lübeck, Department of Cardiology, Angiology and Intensive Care Medicine, University Heart Center Lübeck, University Hospital Schleswig-Holstein – sequence: 6 givenname: Moritz surname: Seiffert fullname: Seiffert, Moritz organization: German Center for Cardiovascular Research (DZHK), Partner Sie Hamburg-Kiel-Lübeck, University Heart and Vascular Center Hamburg – sequence: 7 givenname: Jan-Malte surname: Sinning fullname: Sinning, Jan-Malte organization: Department of Cardiology, St Vinzenz Hospital – sequence: 8 givenname: Raffi surname: Bekeredjian fullname: Bekeredjian, Raffi organization: Department of Cardiology and Angiology, Robert-Bosch-Krankenhaus – sequence: 9 givenname: Thomas surname: Walther fullname: Walther, Thomas organization: Department of Cardiovascular Surgery, University Hospital Frankfurt and Goethe University Frankfurt – sequence: 10 givenname: Friedhelm surname: Beyersdorf fullname: Beyersdorf, Friedhelm organization: Department of Cardiovascular Surgery, Heart Centre Freiburg University – sequence: 11 givenname: Helge surname: Möllmann fullname: Möllmann, Helge organization: The Department of Internal Medicine, St.-Johannes-Hospital Dortmund – sequence: 12 givenname: Ümniye surname: Balaban fullname: Balaban, Ümniye organization: Institute of Biostatistics and Mathematical Modelling, Goethe-University – sequence: 13 givenname: Kaveh surname: Eghbalzadeh fullname: Eghbalzadeh, Kaveh organization: Department of Cardiothoracic Surgery, University Hospital Cologne – sequence: 14 givenname: Tanja K. surname: Rudolph fullname: Rudolph, Tanja K. organization: Department for General and Interventional Cardiology/Angiology, Heart and Diabetes Center North Rhine-Westphalia Bochum, University Hospital of the Ruhr University – sequence: 15 givenname: Sabine surname: Bleiziffer fullname: Bleiziffer, Sabine email: sbleiziffer@hdz-nrw.de organization: Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, University Hospital Ruhr-University Bochum |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38436739$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UU1rFTEUDVKxH_oHXEjATTejNx-TSdzIo2gtFAWpBVchb3KnpsxLajIj9t-b8dWndtFFyA0559xz7zkkezFFJOQ5g1cMoHtdAIThDXC5HOCNeUQOmFasAWX43q7Wcp8clnIN0DIQ8gnZF1oK1QlzQC4_ptgMuEnZjXRI_VzQ0ym7WNzPMI4u31LX91gKDZFerC7P3tDT1eev1LvJURfdeFtCqYWnwzzNGSsXoy9PyePBjQWf3d1H5Mv7dxcnH5rzT6dnJ6vzppddOzVGcg6ATKFiyolubVB6PniHng1-bUD7VgMXppWDU6BRo1RyLYHVV2u4OCJvt7o383qDvsdYvY_2JodNtW6TC_b_nxi-2av0wzJmmDBiUTi-U8jp-4xlsptQeqyjR0xzsdyITgitjajQl_eg12nOdQfFCtZ1RrdC6Yp68a-lnZc_O68AvgX0OZWScdhBGNglWLsN1tZQ7e9g7ULS90h9mNwU0jJWGB-mii211D7xCvNf2w-wfgFf5rY2 |
CitedBy_id | crossref_primary_10_3390_jcdd11070201 |
Cites_doi | 10.1093/eurheartj/suaa050 10.1016/j.jcin.2019.01.219 10.1016/j.jcin.2022.12.009 10.1016/j.amjcard.2020.01.021 10.3389/fcvm.2022.798154 10.1093/eurheartj/ehab395 10.1093/eurheartj/ehy699 10.1016/j.athoracsur.2020.01.074 10.1016/j.athoracsur.2020.09.002 10.1093/ejcts/ezab216 10.1002/ccd.27416 10.1161/CIRCULATIONAHA.114.012525 10.1007/s11886-015-0694-5 10.1016/j.amjcard.2018.07.025 10.1055/s-0032-1323155 10.3390/jcm10071344 10.1016/j.jcin.2018.11.008 10.1002/ccd.27653 10.21037/jtd.2019.12.07 10.1007/s00392-022-01997-1 10.1080/24748706.2018.1497237 10.1016/j.jacc.2020.09.595 10.1136/bmj.i5130 10.1007/s11886-016-0788-8 10.1056/NEJMoa1814052 10.1016/j.jcin.2017.09.023 10.1016/j.jacc.2019.09.054 10.1136/bmjopen-2021-054222 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). Copyright Springer Nature B.V. Mar 2025 The Author(s) 2024 2024 |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: Copyright Springer Nature B.V. Mar 2025 – notice: The Author(s) 2024 2024 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 8FD FR3 K9. M7Z P64 7X8 5PM |
DOI | 10.1007/s00392-024-02402-9 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biochemistry Abstracts 1 Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Biochemistry Abstracts 1 ProQuest Health & Medical Complete (Alumni) Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | Biochemistry Abstracts 1 MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1861-0692 |
EndPage | 331 |
ExternalDocumentID | PMC11913932 38436739 10_1007_s00392_024_02402_9 |
Genre | Multicenter Study Journal Article |
GeographicLocations | Germany |
GeographicLocations_xml | – name: Germany |
GrantInformation_xml | – fundername: Universitätsklinikum Köln (8977) – fundername: Deutsches Zentrum fuer Herz-Kreislauf Forschung |
GroupedDBID | --- -Y2 .VR 06C 06D 0R~ 0VY 1N0 203 29B 29~ 2J2 2JN 2JY 2KG 2LR 2P1 2VQ 2~H 30V 4.4 406 408 409 40D 40E 53G 5GY 5VS 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDBE ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACZOJ ADBBV ADHIR ADHKG ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ASPBG AVWKF AXYYD AYFIA AZFZN B-. BA0 BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C6C CAG CCPQU COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LLZTM M1P M4Y MA- N2Q N9A NB0 NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM P9S PF0 PHGZT PQQKQ PROAC PSQYO PT4 Q2X QOR QOS R89 R9I ROL RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TT1 TUC U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 ZMTXR ZOVNA ~KM AAYXX ABBRH ABFSG ABRTQ ACSTC AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR CITATION PHGZM PJZUB PPXIY CGR CUY CVF ECM EIF NPM 8FD FR3 K9. M7Z P64 7X8 5PM |
ID | FETCH-LOGICAL-c475t-942200e16e616a37b9e4d2fdaed1fdb908d58023954fa608e8e464b401a605923 |
IEDL.DBID | C6C |
ISSN | 1861-0684 1861-0692 |
IngestDate | Thu Aug 21 18:40:16 EDT 2025 Fri Sep 05 00:13:27 EDT 2025 Fri Jul 25 21:12:01 EDT 2025 Sun May 11 01:41:26 EDT 2025 Tue Aug 05 12:02:13 EDT 2025 Thu Apr 24 23:08:23 EDT 2025 Tue Mar 18 01:10:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Transapical Transaortic GARY Transaxillary Transsubclavian TAVI Transfemoral |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c475t-942200e16e616a37b9e4d2fdaed1fdb908d58023954fa608e8e464b401a605923 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-7746-8723 |
OpenAccessLink | https://doi.org/10.1007/s00392-024-02402-9 |
PMID | 38436739 |
PQID | 3177985368 |
PQPubID | 326353 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11913932 proquest_miscellaneous_2937338893 proquest_journals_3177985368 pubmed_primary_38436739 crossref_primary_10_1007_s00392_024_02402_9 crossref_citationtrail_10_1007_s00392_024_02402_9 springer_journals_10_1007_s00392_024_02402_9 |
PublicationCentury | 2000 |
PublicationDate | 2025-03-01 |
PublicationDateYYYYMMDD | 2025-03-01 |
PublicationDate_xml | – month: 03 year: 2025 text: 2025-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
PublicationTitle | Clinical research in cardiology |
PublicationTitleAbbrev | Clin Res Cardiol |
PublicationTitleAlternate | Clin Res Cardiol |
PublicationYear | 2025 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | Y Zhan (2402_CR9) 2019; 11 MM Meertens (2402_CR23) 2022; 111 SL Swift (2402_CR18) 2021; 11 D Eckner (2402_CR26) 2021; 10 JD Carroll (2402_CR14) 2020; 76 JS Patel (2402_CR7) 2016; 18 A Habertheuer (2402_CR29) 2020; 110 CJ Chung (2402_CR22) 2022; 17 N Buzzatti (2402_CR15) 2020; 22 D Caruso (2402_CR6) 2016; 18 L Stastny (2402_CR11) 2022; 9 N Kumar (2402_CR3) 2018; 122 AA Khan (2402_CR4) 2018; 2 F Beyersdorf (2402_CR20) 2021; 60 HK Abdelaziz (2402_CR25) 2020; 125 S Beurtheret (2402_CR1) 2019; 74 DM Arnett (2402_CR8) 2018; 91 MJ Mack (2402_CR2) 2019; 380 JD Carroll (2402_CR13) 2021; 111 TG Dahle (2402_CR24) 2019; 12 SV Arnold (2402_CR28) 2019; 12 RA Siemieniuk (2402_CR19) 2016; 354 A Beckmann (2402_CR10) 2012; 60 P Tullio (2402_CR12) 2023; 16 A Vahanian (2402_CR5) 2021; 43 R Bekeredjian (2402_CR21) 2019; 40 S Elmariah (2402_CR17) 2017; 10 I Ates (2402_CR27) 2018; 91 EH Blackstone (2402_CR16) 2015; 131 |
References_xml | – volume: 22 start-page: E7 issue: Supplement_E year: 2020 ident: 2402_CR15 publication-title: Eur Hear J Suppl doi: 10.1093/eurheartj/suaa050 – volume: 12 start-page: 662 issue: 7 year: 2019 ident: 2402_CR24 publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2019.01.219 – volume: 16 start-page: 396 issue: 4 year: 2023 ident: 2402_CR12 publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2022.12.009 – volume: 125 start-page: 1239 issue: 8 year: 2020 ident: 2402_CR25 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2020.01.021 – volume: 9 start-page: 798154 year: 2022 ident: 2402_CR11 publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2022.798154 – volume: 43 start-page: 561 issue: 7 year: 2021 ident: 2402_CR5 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehab395 – volume: 40 start-page: 1323 issue: 17 year: 2019 ident: 2402_CR21 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy699 – volume: 110 start-page: 1294 issue: 4 year: 2020 ident: 2402_CR29 publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2020.01.074 – volume: 17 start-page: 1514 issue: 18 year: 2022 ident: 2402_CR22 publication-title: EuroIntervention J Eur Collab with Work Gr Interv Cardiol Eur Soc Cardiol – volume: 111 start-page: 701 issue: 2 year: 2021 ident: 2402_CR13 publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2020.09.002 – volume: 60 start-page: 1139 issue: 5 year: 2021 ident: 2402_CR20 publication-title: Eur J Cardio-Thoracic Surg doi: 10.1093/ejcts/ezab216 – volume: 91 start-page: 150 issue: 1 year: 2018 ident: 2402_CR8 publication-title: Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv doi: 10.1002/ccd.27416 – volume: 131 start-page: 1989 issue: 22 year: 2015 ident: 2402_CR16 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.012525 – volume: 18 start-page: 14 issue: 2 year: 2016 ident: 2402_CR6 publication-title: Curr Cardiol Rep doi: 10.1007/s11886-015-0694-5 – volume: 122 start-page: 1520 issue: 9 year: 2018 ident: 2402_CR3 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2018.07.025 – volume: 60 start-page: 319 issue: 5 year: 2012 ident: 2402_CR10 publication-title: Thorac Cardiovasc Surg doi: 10.1055/s-0032-1323155 – volume: 10 start-page: 1344 issue: 7 year: 2021 ident: 2402_CR26 publication-title: J Clin Med doi: 10.3390/jcm10071344 – volume: 12 start-page: 362 issue: 4 year: 2019 ident: 2402_CR28 publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2018.11.008 – volume: 91 start-page: 1363 issue: 7 year: 2018 ident: 2402_CR27 publication-title: Catheter Cardiovasc Interv Off J Soc Card Angiogr & Interv doi: 10.1002/ccd.27653 – volume: 11 start-page: 5140 issue: 12 year: 2019 ident: 2402_CR9 publication-title: J Thorac Dis doi: 10.21037/jtd.2019.12.07 – volume: 111 start-page: 843 issue: 8 year: 2022 ident: 2402_CR23 publication-title: Clin Res Cardiol doi: 10.1007/s00392-022-01997-1 – volume: 2 start-page: 463 issue: 5 year: 2018 ident: 2402_CR4 publication-title: Struct Hear doi: 10.1080/24748706.2018.1497237 – volume: 76 start-page: 2492 issue: 21 year: 2020 ident: 2402_CR14 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.09.595 – volume: 354 start-page: i5130 year: 2016 ident: 2402_CR19 publication-title: BMJ doi: 10.1136/bmj.i5130 – volume: 18 start-page: 110 issue: 11 year: 2016 ident: 2402_CR7 publication-title: Curr Cardiol Rep doi: 10.1007/s11886-016-0788-8 – volume: 380 start-page: 1695 issue: 18 year: 2019 ident: 2402_CR2 publication-title: N Engl J Med doi: 10.1056/NEJMoa1814052 – volume: 10 start-page: 2414 issue: 23 year: 2017 ident: 2402_CR17 publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2017.09.023 – volume: 74 start-page: 2728 issue: 22 year: 2019 ident: 2402_CR1 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2019.09.054 – volume: 11 start-page: e054222 issue: 12 year: 2021 ident: 2402_CR18 publication-title: BMJ Open doi: 10.1136/bmjopen-2021-054222 |
SSID | ssj0051034 |
Score | 2.4111052 |
Snippet | Background
In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.
Aim
To evaluate... In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen. To evaluate the use and... BackgroundIn patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.AimTo evaluate the... In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.BACKGROUNDIn patients not... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 323 |
SubjectTerms | Aged Aged, 80 and over Aorta Aortic valve Aortic Valve - surgery Aortic Valve Stenosis - mortality Aortic Valve Stenosis - surgery Axillary Artery Body mass index Cardiology Cardiovascular disease Data analysis Female Femoral Artery Germany - epidemiology Heart valves Humans Length of stay Male Medicine Medicine & Public Health Mortality Original Paper Patients Propensity Score Registries Retrospective Studies Subgroups Survival Survival Rate - trends Transcatheter Aortic Valve Replacement - methods Transcatheter Aortic Valve Replacement - trends Treatment Outcome Trends |
Title | Non-femoral focused transaxillary access in TAVI: GARY data analysis and future trends |
URI | https://link.springer.com/article/10.1007/s00392-024-02402-9 https://www.ncbi.nlm.nih.gov/pubmed/38436739 https://www.proquest.com/docview/3177985368 https://www.proquest.com/docview/2937338893 https://pubmed.ncbi.nlm.nih.gov/PMC11913932 |
Volume | 114 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwED_Ugfgifls_RgTftLC2adr6NodzKtuDTHFPJV1SHEgr-wD9773Luso2FXwobeklbZNc8jvu8juAc7QYFNpcnl0L0DbhjpvaMgmULQWXNd13uVC0ObndEa0nfv_ivxQ0ObQXZsF_T2SfHsVHupwO1N5oFSo-Trw0mhuiMZt1iRjOeJBDQZE8IS82yPxcx_witIQslwMkF7ykZvFpbsFmgRpZfdrN27Cisx1Ybxd-8V147uSZnVLQLEqleX8y0oqNTSrwD0orNPxk0mRGZIOMdevPd1fstv7YYxQfymTBS4IXik05RrAshcruwVPzptto2UXGBLvPA39sR9zFUa8doYUjpBckkebKTZXUyklVEtVC5RPjW-TzVIpaqEPNBU_QxsI7H7HePqxleaYPgaWBkp4BFEJxw5KWiATRHpXwsXoLnFkTxv2CTpyyWrzFJRGyafYYmzw2zR5HFlyUZd6nZBp_Sp_MeiYuFGsUI9wJIoQYIrTgrHyMKkF-DpnpfDKKEcEEaHkjErPgYNqR5eu8kHsi8LDycK6LSwGi255_kg1eDe02UeF5CHctuJyNhu_v-v03jv4nfgwbLqUYNmFuJ7A2Hk70KeKecVKFSr15fd2h823v4aZqFOALxYv4Xg |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwED_8APVF_LZ-RvBNC2ubpq1vY6jzY3uQbehTSJcUBenEbaD_vXdZV9mmgg-Fll7S9i5pfsddfgdwih6DRp8rcCsR-ibc8zNXpZF2leCqYro-F5o2Jzeaot7mt4_hY0GTQ3thpuL3RPYZUH6kz-nA2ZvMwyJFLoknvyZq478uEcPZCHIsKJMn5sUGmZ_7mFyEZpDlbILkVJTULj5Xa7BaoEZWHZl5HeZMvgFLjSIuvgmdZi93M0qaRams1x32jWYDWwr8g8oKvX8yZSsjspectaqdmwt2XX14YpQfylTBS4Inmo04RrAtpcpuQfvqslWru0XFBLfLo3DgJtzHUW88YYQnVBClieHaz7Qy2st0mlRiHRLjWxLyTIlKbGLDBU_Rx8KrELHeNizkvdzsAssirQILKITmliUtFSmiPWoRYvcOeGMVym5BJ05VLV5lSYRs1S5R5dKqXSYOnJVt3kZkGn9KH4wtI4uJ1ZcId6IEIYaIHTgpb-OUoDiHyk1v2JeIYCL0vBGJObAzMmT5uCDmgYgC7DyeMHEpQHTbk3fyl2dLu01UeAHCXQfOx6Ph-71-_4y9_4kfw3K91biX9zfNu31Y8ancsE15O4CFwfvQHCIGGqRHdvB_AQby-D0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3rS9xAEB_aE6Rf1NpW46Ndod_a6CXZbBK_Her5PkpR0U_LJrtBUXLi5UD9653ZPOppWyj9EEjYR7KPyf6GmfkNwFfUGDTqXIHbjVA34Z6fuyqNtKsEV12T-VxoCk4-Hoi9U35wHp4_i-K33u6NSbKKaSCWpqLcuNX5Rhv4RiGlvovnC10o08lbmOKUQ6IDU73di8Od5m9MhHHWshwL8vCJeR048_teJg-nV4jztePkC-upPZT6s6Ca4VS-KNfr4zJdzx5fMD3-z3jnYKZGrKxXbbH38MYU8zB9XNvkP8DZYFi4OTnsYq18mI1HRrPSpiG_p5RGdw9M2ayM7KpgJ72z_U222_t5wcg3lamaEwVvNKv4TbAtuel-hNP-zsnWnltna3AzHoWlm3AfJc54wghPqCBKE8O1n2tltJfrNOnGOiS2uSTkuRLd2MSGC56ifodPIeLMT9AphoVZBJZHWgUWzAjNLUNbKlJEmtQixO4d8JplkllNZU4ZNW5kS8JsJ0ziZEk7YTJx4Fvb5rYi8vhr7ZVm9WUt1COJUCtKEN6I2IG1thjFkWwsqjDD8UgieopQ60cU6MBCtVna1wUxD0QUYOfxxDZqKxDV92RJcXVpKb-Jhi9AqO3A92az_PquPw9j6d-qf4HpH9t9ebQ_OFyGdz5lOrbedivQKe_GZhXhV5l-riXsCUocIj4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Non-femoral+focused+transaxillary+access+in+TAVI%3A+GARY+data+analysis+and+future+trends&rft.jtitle=Clinical+research+in+cardiology&rft.au=Meertens%2C+Max+M.&rft.au=Adam%2C+Matti&rft.au=Beckmann%2C+Andreas&rft.au=Ensminger%2C+Stephan&rft.date=2025-03-01&rft.issn=1861-0684&rft.eissn=1861-0692&rft.volume=114&rft.issue=3&rft.spage=323&rft.epage=331&rft_id=info:doi/10.1007%2Fs00392-024-02402-9&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00392_024_02402_9 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1861-0684&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1861-0684&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1861-0684&client=summon |